Macrophages are a part of organism defense system. They remove pathogenic microorganism and other pathogenic compounds, give an activation signal to the immune system cells. They also can detect antigens opsonized with antibodies and internalize them [1]. Therefore, macrophages might have an impact on the efficiency of antigen elimination in certain diseases. However, in many cases it is unknown how macrophages are activated with potentially pathogenic proteins. For example, detailed mechanism of macrophage/microglia activation with $\beta$-amyloid (A$\beta$) during Alzheimer's disease is unknown [2]. As well as, the pathway of macrophage activation with immune complexes (IC) is unclear as certain side effects of anti-A$\beta$ therapy have been shown in treatment of AD [3].
The aim of the current research was to investigate the influence of A$\beta$ oligomers and viral oligomers (measles virus, WU polyomavirus and metapneumovirus) and their immune complexes (IC) on macrophage phenotype. The research model was primary spleen cell culture from BALB/c mice. We generated macrophage from splenic monocytes and used this culture in our research. The variations in the levels of cell markers – inflammatory macrophage M1 markers and anti-inflammatory macrophage M2 markers – were investigated by flow cytometry and ELISA.
Our results showed generation of both M1 and M2 phenotype after macrophages treatment with A$\beta$ oligomers and their IC. The IC induced higher expression of M2-related marker IL-10 compared to A$\beta$ oligomers alone. Higher levels of IL-10 may indicate a negative impact of IC on the phagocytic degradation of A$\beta$ oligomers. Macrophage treatment with oligomeric viral antigens and their IC induced the inflammatory phenotype of macrophages. However, the activation signal was lower compared to A$\beta$ oligomers. In conclusion, the activation of macrophages with oligomeric proteins and their IC can induce different signals and lead either to the inflammatory or anti-inflammatory phenotype depending on the origin and structure of the oligomeric proteins.